Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel Free RSLS Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

ReShape Lifesciences (RSLS) Short Interest Ratio & Short Volume

ReShape Lifesciences logo
Compare

ReShape Lifesciences Short Interest Overview

As of July 31, 2025, ReShape Lifesciences (RSLS) had a short interest of 209,000 shares sold short, representing 9.54% of the public float. This marks a 12.79% increase in short interest since the prior report. The short interest ratio (days to cover) is 0.1, meaning it would take 0.1 days of the average trading volume of 716,441 shares to cover all short positions.

Current Short Interest
209,000 shares
Previous Short Interest
185,300 shares
Change Vs. Previous Month
12.79%
Dollar Volume Sold Short
$509.96 thousand
Short Interest Ratio
0.1 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
2,690,000 shares
Float Size
2,190,000 shares
Short Percent of Float
9.54%
Today's Trading Volume
13,689,666 shares
Average Trading Volume
716,441 shares
Today's Volume Vs. Average
1,911%
Short Selling ReShape Lifesciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for ReShape Lifesciences and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

RSLS Short Interest Over Time

RSLS Days to Cover Over Time

RSLS Percentage of Float Shorted Over Time

ReShape Lifesciences Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/2025209,000 shares $509.96 thousand +12.8%9.5%0.1 $2.44
7/15/2025185,300 shares $496.60 thousand -10.2%8.5%0.1 $2.68
6/30/2025206,300 shares $503.37 thousand -78.2%9.4%0.1 $2.44
6/15/2025947,000 shares $2.39 million +2,710.1%43.2%0.3 $2.52
5/31/202533,700 shares $161.76 thousand -23.4%4.8%0 $4.80
5/15/202544,000 shares $263.12 thousand -39.6%6.3%0.1 $5.98
4/30/202572,900 shares $616.92 thousand -93.0%N/A0.1 $8.46
4/15/20251,040,000 shares $395.20 thousand +51.0%11.3%0.1 $0.38
3/31/2025688,700 shares $248.28 thousand +87.6%7.5%0.1 $0.36
3/15/2025367,200 shares $233.36 thousand -22.1%50.4%0.3 $0.64
2/28/2025471,600 shares $485.75 thousand +469.6%64.7%0.4 $1.03
2/15/202582,800 shares $192.92 thousand +266.4%62.6%0.1 $2.33
1/31/202522,600 shares $86.90 thousand +40.4%3.3%0.4 $3.85
1/15/202516,100 shares $79.37 thousand -13.0%2.3%0.2 $4.93
12/31/202418,500 shares $82.51 thousand -38.1%2.7%0.2 $4.46
12/15/202429,900 shares $141.13 thousand +25.6%4.4%0.3 $4.72
11/30/202423,800 shares $141.37 thousand -70.9%3.6%0.1 $5.94
11/15/202481,700 shares $428.11 thousand +226.8%12.4%0.4 $5.24
10/31/202425,000 shares $141.25 thousand +70.1%5.3%0.1 $5.65
10/15/202414,700 shares $83.20 thousand -74.3%3.1%0.1 $5.66
9/30/202457,200 shares $323.18 thousand +472.0%12.2%0.4 $5.65
9/15/202410,000 shares $1.68 thousand -98.3%N/A0.1 $0.17
8/31/2024585,200 shares $94.22 thousand -26.0%2.2%0.4 $0.16
8/15/2024791,000 shares $139.30 thousand +16.3%3.0%0.1 $0.18
7/31/2024680,000 shares $132.67 thousand -60.5%2.6%0.1 $0.20
7/15/20241,720,000 shares $391.64 thousand +272.0%6.6%0.3 $0.23
6/30/2024462,400 shares $88.60 thousand +104.2%2.2%0.1 $0.19
6/15/2024226,500 shares $44.35 thousand -89.6%1.1%0 $0.20
5/31/20242,170,000 shares $553.13 thousand +598.7%10.4%0.4 $0.25
5/15/2024310,600 shares $54.04 thousand -11.3%1.5%0.5 $0.17
4/30/2024350,100 shares $58.12 thousand -28.2%1.7%0.8 $0.17
4/15/2024487,800 shares $80.24 thousand -33.1%2.3%0.9 $0.16
3/31/2024729,300 shares $134.48 thousand +70.1%3.5%0.9 $0.18
3/15/2024428,700 shares $69.66 thousand -43.3%2.1%0.4 $0.16
2/29/2024756,200 shares $127.27 thousand -9.0%4.0%0.1 $0.17
2/15/2024830,800 shares $143.06 thousand -3.7%4.4%0.2 $0.17
1/31/2024862,400 shares $180.33 thousand -41.3%4.6%0.2 $0.21
1/15/20241,470,000 shares $378.67 thousand +102.2%14.0%0.2 $0.26
12/31/2023726,900 shares $181.51 thousand -93.6%5.6%0.1 $0.25
12/15/202311,270,000 shares $3.73 million +5,386.9%86.9%1.5 $0.33
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
11/30/2023205,400 shares $46.85 thousand -66.6%1.6%0.1 $0.23
11/15/2023614,800 shares $150.20 thousand -63.2%4.7%0.2 $0.24
10/31/20231,670,000 shares $413.66 thousand +77.7%14.0%0.5 $0.25
10/15/2023939,900 shares $284.60 thousand +178.7%7.9%0.5 $0.30
9/30/2023337,300 shares $114.01 thousand +112.8%2.8%1.5 $0.34
9/15/2023158,500 shares $118.08 thousand +335.4%4.8%1.1 $0.75
8/31/202336,400 shares $33.86 thousand +658.3%1.1%0.2 $0.93
8/15/20234,800 shares $5.71 thousand -79.1%0.2%0 $1.19
7/31/202323,000 shares $32.66 thousand +12.2%0.8%0.1 $1.42
7/15/202320,500 shares $30.75 thousand -74.8%0.7%0.1 $1.50
6/30/202381,300 shares $120.32 thousand +95.0%2.9%0.3 $1.48
6/15/202341,700 shares $91.74 thousand -59.6%1.5%0.1 $2.20
5/31/2023103,100 shares $249.50 thousand -7.9%3.7%0.4 $2.42
5/15/2023111,900 shares $275.27 thousand -11.8%4.0%0.4 $2.46
6/15/2021100 shares $213.33 No ChangeN/A0.1 $2.13
5/28/2021100 shares $620.00 No ChangeN/A0.1 $6.20

RSLS Short Interest - Frequently Asked Questions

Short interest is the volume of ReShape Lifesciences shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 209,000 shares of RSLS short. 9.54% of ReShape Lifesciences' shares are currently sold short. Learn More on ReShape Lifesciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RSLS shares currently have a short interest ratio of 0.1. Learn More on ReShape Lifesciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.54% of ReShape Lifesciences' floating shares are currently sold short.

ReShape Lifesciences saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 209,000 shares, an increase of 12.8% from the previous total of 185,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

ReShape Lifesciences currently has issued a total of 2,690,000 shares. Some of ReShape Lifesciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ReShape Lifesciences currently has a public float of 2,190,000 shares.

9.54% of ReShape Lifesciences' shares are currently sold short. Here is how the short interest of companies compare to ReShape Lifesciences: Rockwell Medical, Inc. (1.00%), Intuitive Surgical, Inc. (1.90%), Abbott Laboratories (1.30%), Stryker Corporation (1.21%), Medtronic PLC (1.14%), Boston Scientific Corporation (1.93%), Edwards Lifesciences Corporation (1.84%), IDEXX Laboratories, Inc. (2.66%), Becton, Dickinson and Company (2.32%), ResMed Inc. (8.50%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

Short selling RSLS is an investing strategy that aims to generate trading profit from ReShape Lifesciences as its price is falling. RSLS shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for ReShape Lifesciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RSLS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RSLS, twice per month. The most recent reporting period available is July, 31 2025.

Understanding short interest metrics can help you assess how traders are positioning around a stock like RSLS:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:RSLS) was last updated on 5/16/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
Oil is settling in yuan now - here's what that means for gold
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trading legend: “I made millions for CEO clients just repeating this 1 secret”
TradeSmith Senior Analyst Jeff Clark has guided readers through 300-plus winning trades over 9 years - across ...
TradeSmith | Sponsoredtc pixel